16-1962546-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002952.4(RPS2):c.660T>A(p.Asp220Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,611,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002952.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249568Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135584
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1459488Hom.: 0 Cov.: 33 AF XY: 0.00000826 AC XY: 6AN XY: 726072
GnomAD4 genome AF: 0.000131 AC: 20AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.660T>A (p.D220E) alteration is located in exon 6 (coding exon 5) of the RPS2 gene. This alteration results from a T to A substitution at nucleotide position 660, causing the aspartic acid (D) at amino acid position 220 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at